Transactions With Shares and Linked Securities in Genmab AS Made by Managerial Employees and Their Closely Associated Persons
| GMAB Stock | USD 19.35 0.12 0.62% |
About 62% of Genmab AS's investor base is looking to short. The analysis of overall sentiment of trading Genmab AS stock suggests that many investors are alarmed at this time. The current market sentiment, together with Genmab AS's historical and current headlines, can help investors time the market. In addition, many technical investors use Genmab AS stock news signals to limit their universe of possible portfolio assets.
Genmab |
Company Announcement COPENHAGEN, Denmark December 3, 2024 Genmab AS In accordance with Article 19 of Regulation No. 5962014 on Market Abuse and Implementing Regulation 2016523, this document discloses the data of the transactions made in Genmab AS made by managerial employees and their closely associated persons. The companys managerial employees and their closely associated persons have given Genmab AS power of attorney on their behalf to publish trading
Read at finance.yahoo.com
 |
Genmab AS Fundamental Analysis
We analyze Genmab AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genmab AS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genmab AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Genmab AS is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Genmab AS Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Genmab AS stock to make a market-neutral strategy. Peer analysis of Genmab AS could also be used in its relative valuation, which is a method of valuing Genmab AS by comparing valuation metrics with similar companies.
Peers
Genmab AS Related Equities
| TERN | Terns Pharmaceuticals | 3.10 | ||||
| TVTX | Travere Therapeutics | 3.06 | ||||
| DAWN | Day One | 2.37 | ||||
| AMLX | Amylyx Pharmaceuticals | 1.63 | ||||
| PCVX | Vaxcyte | 0.36 | ||||
| APLS | Apellis Pharmaceuticals | 0.56 | ||||
| BPMC | Blueprint Medicines | 0.68 | ||||
| ALEC | Alector | 2.72 | ||||
| ASND | Ascendis Pharma | 3.39 | ||||
| LEGN | Legend Biotech | 4.40 | ||||
| EWTX | Edgewise Therapeutics | 4.46 | ||||
| AKRO | Akero Therapeutics | 4.53 | ||||
| CYTK | Cytokinetics | 8.41 |
Complementary Tools for Genmab Stock analysis
When running Genmab AS's price analysis, check to measure Genmab AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genmab AS is operating at the current time. Most of Genmab AS's value examination focuses on studying past and present price action to predict the probability of Genmab AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genmab AS's price. Additionally, you may evaluate how the addition of Genmab AS to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |